What treatment is commonly prescribed for postpartum preeclampsia?

The treatment commonly prescribed for postpartum preeclampsia is IV magnesium sulfate. This treatment is critical because magnesium sulfate acts as a potent anticonvulsant and helps to prevent the occurrence of seizures in women who are experiencing preeclampsia or its more severe form, eclampsia. In the postpartum period, women remain at risk for developing seizures due to elevated blood pressure and related complications stemming from preeclampsia, which can persist even after delivery.

Magnesium sulfate is administered intravenously, allowing for quick and effective blood concentration levels, which is essential for immediate medical management. The administration typically begins in a hospital setting where continuous monitoring of the mother's blood pressure and neurological status can be conducted. By controlling the risk of seizures and managing blood pressure, magnesium sulfate plays a crucial role in ensuring maternal safety during the critical postpartum period.

Other treatments listed, such as oral antihistamines or antibiotic therapy, do not address the underlying causes or symptoms associated with postpartum preeclampsia. The injection of RhoGAM is specific to Rh incompatibility issues and does not relate to the management of preeclampsia. Therefore, IV magnesium sulfate stands out as the appropriate and targeted therapy for this condition.